[Plasma concentrates of factor VIII. Where are we?]

[Article in Spanish]

Review

[Article in Spanish]

V Vicente. Sangre (Barc). 1989 Feb.

. 1989 Feb;34(1):1-3.

No abstract available

Similar articles

Review of the transmission of hepatitis by clotting factor concentrates.
Tabor E. Tabor E. Scand J Haematol Suppl. 1984;40:303-8. doi: 10.1111/j.1600-0609.1984.tb02576.x. Scand J Haematol Suppl. 1984. PMID: 6433456 No abstract available.
Short incubation non-A, non-B hepatitis transmitted by factor VIII concentrates in patients with congenital coagulation disorders: a preliminary report of an antigen/antibody system.
Bamber M, Murray A, Kernoff PB, Thomas HC. Bamber M, et al. Med Lab Sci. 1981 Oct;38(4):373-8. Med Lab Sci. 1981. PMID: 6799726 No abstract available.
[Non-A non-B hepatitis caused by transfusing American antihemophilic globulin (factor VIII) in patients with hemophilia].
Zhang Z, Li YH, Li XF. Zhang Z, et al. Zhonghua Nei Ke Za Zhi. 1988 Feb;27(2):82-4, 134. Zhonghua Nei Ke Za Zhi. 1988. PMID: 3141119 Chinese. No abstract available.
The use of purified clotting factor concentrates in hemophilia. Influence of viral safety, cost, and supply on therapy.
Pierce GF, Lusher JM, Brownstein AP, Goldsmith JC, Kessler CM. Pierce GF, et al. JAMA. 1989 Jun 16;261(23):3434-8. JAMA. 1989. PMID: 2498537 Review.
Viral safety issues: plasma-derived factor VIII.
Berntorp E. Berntorp E. Ann Hematol. 1994;68 Suppl 3:S35-6. doi: 10.1007/BF01774528. Ann Hematol. 1994. PMID: 8180256 Review. No abstract available.